|ME NewsWire / BusinessWire|
CODOLET, France & TURKU, Finland - Tuesday, October 8th 2013
Cisbio Bioassays (www.cisbio.com), global developer of in vitro diagnostic kits and of products and services used in drug discovery, and Orion Diagnostica Oy (www.oriondiagnostica.com), an in vitro diagnostics company specializing in development, production and sales of diagnostic test systems, announced that they have signed an agreement covering raw materials and related documentation for the manufacturing of ultrasensitive Estradiol, Cortisol and Testosterone radioimmunoassays. Cisbio Bioassays plans to start the manufacturing and worldwide marketing of products based on these assets in 2014. Until then, the assays concerned remain available from Orion Diagnostica Oy, under the brand name Spectria.
"These assays demand the high quality manufacturing standards which Cisbio Bioassays sets for its radioimmunoassay production. Adding them to our range will strengthen our leadership in this field" said Berthold Baldus, President, Cisbio Bioassays. "This will undeniably facilitate access to a more complete assay offering for our customer network worldwide".
"We are delighted that through this arrangement Orion Diagnostica Oy’s long term global customers for Spectria radioimmunoassay will have a possibility for continuation with products manufactured by our long term partner.” Jaakko Rissanen, President, Orion Diagnostica Oy said.
About Cisbio Bioassays Cisbio Bioassays, member of the IBA group, is a global provider of products and services used in the field of healthcare and research. Cisbio Bioassays develops in vitro diagnostic assays and produces biological reagents and methods used by pharmaceutical and biotechnology companies for drug discovery. The company is based in Codolet, France, with facilities in Bedford, MA, U.S.A., in Shanghai, China, and a network of distributors worldwide. Visit www.cisbio.com for more information.
About Orion Diagnostica Oy Orion Diagnostica Oy is part of Orion Group, the leading health care company in Finland. Orion Diagnostica develops, manufactures and markets diagnostic tests. It specializes in easy-to-use, cost-effective clinical diagnostic tests and hygiene monitoring solutions designed to improve health care effectiveness and individual well-being. The special focus is on products for primary health care that enable consultation, testing and treatment decisions to be completed during a single patient visit. Visit www.oriondiagnostica.com for further information.
Véronique Cartalas, +33-1-69-85-73-25